Uncategorized

The reorganization formalizes a regional reporting structure and further integrates Novant’s business division across the organization.

Wall Street analysts said current tariffs should be “manageable” for the sector but cautioned that other countries may retaliate.

Hospital occupancy rates were higher in 2024 than 2019. If occupancy rates trend up, the nation could face a bed shortage by 2032, according to researchers.

A cautionary tale illustrates how forging a deal with a Big Pharma can have unexpected and far-reaching tax consequences.

2023 marked the most bankruptcies in biopharma in more than a decade, with 14 companies filing for Chapter 11 protection. The number remained high in 2024.

The agreement, in which Merck will pay the biotech an undisclosed initial sum to license drugs targeting a solid tumor, could net Epitopea up to $300 million down the line.

The news comes on the heels of promising Phase I/Ib data, which point to the potential of casdatifan as a more effective alternative to Merck’s Welireg in renal cell carcinoma.

Recently appointed HHS Secretary Robert F. Kennedy Jr. in 2018 helped bring several cases against vaccine maker Merck, alleging i2025 njury linked to its HPV shot Gardasil.

Exelixis’ next-generation tyrosine kinase inhibitor zanzalintinib is being tested for colorectal cancer, renal cell carcinoma and head-and-neck cancer, with several readouts slated for the second half of 2025.

Executive coaches can help executives take their game to the next level in four key ways, from improving their self-awareness to reshaping their thinking.